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Abstract 
Background/Aims: Psammaplin A, a natural product isolated from marine sponges, triggers 
apoptosis of tumor cells and is thus considered for the treatment of malignancy. In analogy 
to apoptosis of nucleated tumor cells, erythrocytes may enter eryptosis, a suicidal death 
characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine 
translocation to the erythrocyte surface. Cellular mechanisms stimulating eryptosis include 
increase of cytosolic Ca2+ activity ([Ca2+]i), oxidative stress and ceramide. The present study 
explored, whether Psammaplin A induces eryptosis and to possibly shed some light on the 
underlying mechanisms. Methods: Phosphatidylserine exposing erythrocytes were identified 
utilizing annexin-V-binding, cell volume was estimated from forward scatter, [Ca2+]i determined 
utilizing Fluo3-fluorescence, the abundance of reactive oxygen species (ROS) quantified 
with DCFDA dependent fluorescence, and ceramide abundance at the erythrocyte surface 
detected with specific antibodies. Results: A 48 hours exposure of human erythrocytes to 
Psammaplin A (2-8 µg/ml) significantly decreased forward scatter and significantly increased 
the percentage of annexin-V-binding cells. Psammaplin A significantly increased Fluo3-
fluorescence, the effect of Psammaplin A on annexin-V-binding and forward scatter was, 
however, not significantly blunted by removal of extracellular Ca2+. Psammaplin A significantly 
increased DCFDA fluorescence and ceramide abundance. Conclusions: Psammaplin A 
triggers cell shrinkage and phospholipid scrambling of the erythrocyte cell membrane, an 
effect paralleled by increase of [Ca2+]i, induction of oxidative stress and enhanced appearance 
of ceramide. 
IntroductionPsammaplin A, a symmetrical bromotyrosine-derived disulfide isolated from marine sponges [1-5], has previously been shown to trigger apoptosis of tumor cells [6-9] and is considered a potential drug for the treatment of malignancy [6-14]. Psammaplin A inhibits 
histone deacetylase and proved to be a powerful epigenetic modifier [3, 6, 10, 15-21]. In 
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addition, the drug inhibits hepatitis C virus NS3 helicase and has thus been considered as 
antiviral drug [22]. Psammaplin A further inhibits chitinolytic enzymes and has antifungal 
and antibacterial potency [23-27]. Several substances triggering apoptosis of nucleated cells similarly trigger suicidal death of erythrocytes or eryptosis [28-70]. Eryptosis is characterized by cell shrinkage [71] and cell membrane scrambling with phosphatidylserine translocation to the cell surface [59]. Mechanisms involved in the stimulation of eryptosis include increase of cytosolic Ca2+ activity ([Ca2+]i) [59], ceramide [72], oxidative stress [59], energy depletion [59], caspases 
[59, 73, 74], and several kinases, such as casein kinase 1α, Janus-activated kinase JAK3, 
protein kinase C, and p38 kinase [59]. Other kinases, such as AMP activated kinase AMPK, 
cGMP-dependent protein kinase, PAK2 kinase and sorafenib/sunitinib sensitive kinases counteract eryptosis [59].
The present study explored, whether Psammaplin A may trigger eryptosis. To this 
end, human erythrocytes from healthy volunteers were exposed to Psammaplin A and phosphatidylserine translocation, cell volume, [Ca2+]i, oxidative stress, and ceramide abundance determined by flow cytometry. 
Materials and Methods 
Erythrocytes, solutions and chemicalsFresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University 
of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The 
blood was centrifuged at 120 x g for 20 min at 21 °C and the platelets and leukocytes-containing supernatant 
was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in 
mM) 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl
2
, at 37°C for 48 hours. Where indicated, erythrocytes were exposed for 48 hours to Psammaplin 
A (Santa Cruz Biotechnology, Texas, USA).
Annexin-V-binding and forward scatter 
After incubation under the respective experimental condition, a 150 µl cell suspension was washed in 
Ringer solution containing 5 mM CaCl
2
 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, 
Friesoythe, Germany) in this solution at 37°C for 15 min under protection from light. The annexin-V-
abundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, 
Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission 
wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding cells and control cells. The same threshold was used for untreated and Psammaplin A treated erythrocytes. 
Intracellular Ca2+
After incubation, erythrocytes were washed in Ringer solution and then loaded with Fluo-3/AM 
(Biotium, Hayward, USA) in Ringer solution containing 5 mM CaCl
2
 and 5 µM Fluo-3/AM. The cells were 
incubated at 37°C for 30 min and washed once in Ringer solution containing 5 mM CaCl
2
. The Fluo-3/
AM-loaded erythrocytes were resuspended in 200 µl Ringer solution. Then, Ca2+-dependent fluorescence 
intensity was measured in FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 
530 nm on a FACS Calibur. Afterwards, the geomean of the Ca2+ dependent fluorescence was determined.
Reactive oxygen species (ROS) 
Oxidative stress was determined utilizing 2’,7’-dichlorodihydrofluorescein diacetate (DCFDA). After 
incubation, a 150 µl suspension of erythrocytes was washed in Ringer solution and stained with DCFDA 
(Sigma, Schnelldorf, Germany) at a final concentration of 10 µM. Erythrocytes were incubated at 37°C 
for 30 min in the dark and washed two times in Ringer solution. The DCFDA-loaded erythrocytes were 
resuspended in 200 µl Ringer solution and ROS-dependent fluorescence intensity was measured in FL-1 
at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD). 
Subsequently, the geomean of the DCFDA dependent fluorescence was determined.
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Ceramide abundanceTo determine the ceramide abundance at the erythrocyte surface, a monoclonal antibody was used. 
After incubation, cells were stained for 1 h at 37°C with 1 μg/ml anti-ceramide antibody (clone MID 15B4; 
Alexis, Grünberg, Germany) in phosphate-buffered saline (PBS) containing 0.1 % bovine serum albumin 
(BSA) at a dilution of 1:10. After two washing steps with PBS-BSA, cells were stained for 30 min with 
polyclonal fluorescein-isothiocyanate (FITC)-conjugated goat anti-mouse IgG/IgM (concentration 0.5 mg/
ml) specific antibody (BD Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. Unbound secondary 
antibody was removed by repeated washing with PBS-BSA. Samples were then analyzed by flow cytometric 
analysis in FL-1 at an excitation wavelength of 488 nm and an emission wavelength of 530 nm. Finally, the 
geomean of the ceramide dependent fluorescence was determined.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis 
was made using ANOVA with Tukey’s test as post-test and t test as appropriate. n denotes the number of 
different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control 
and experimental conditions.
ResultsThe present study aimed to possibly disclose an effect of Psammaplin A on eryptosis, 
the suicidal erythrocyte death, which is characterized by cell shrinkage and phospholipid scrambling of the cell membrane with phosphatidylserine translocation to the cell surface. 
Forward scatter in flow cytometry was taken as measure of erythrocyte volume. The 
measurements were performed after a 48 hours incubation of the erythrocytes in Ringer 
solution without or with Psammaplin A (2 – 8 µg/ml). As shown in Fig. 1, Psammaplin A 
significantly decreased erythrocyte forward scatter at all Psammaplin A concentrations tested. 
Phosphatidylserine exposing erythrocytes were identified utilizing annexin-V-binding, 
which was quantified by flow cytometry. The measurements were again made after a 48 
hours incubation of the erythrocytes in Ringer solution without or with Psammaplin A (2 
Fig. 1. Effect of Psammaplin A on erythrocyte forward scatter. A. Original histogram of forward scatter of 
erythrocytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) 
presence of 8 µg/ml Psammaplin A. B. Arithmetic means ± SEM (n = 8) of the erythrocyte forward scatter 
(FSC) following incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Psam-
maplin A (2 - 8 µg/ml). For comparison, the effect of the solvent DMSO is shown (grey bar). ***(p<0.001) 
indicates significant difference from the absence of Psammaplin A (ANOVA).
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– 8 µg/ml). As illustrated in Fig. 2, a 48 hours exposure to Psammaplin A (2 – 8 µg/ml) 
significantly increased the percentage of phosphatidylserine exposing erythrocytes. Cytosolic Ca2+ activity ([Ca2+]i) was estimated utilizing Fluo3 fluorescence. The 
measurements were again made after a 48 hours incubation of the erythrocytes in Ringer 
solution without or with Psammaplin A (2 – 8 µg/ml). As apparent from Fig. 3, a 48 hours 
exposure to Psammaplin A (2 – 8 µg/ml) increased the Fluo3 fluorescence, an effect 
statistically significant at all Psammaplin A concentrations tested. 
In order to test, whether the Psammaplin A-induced cell shrinkage and translocation 
of phosphatidylserine or erythrocyte shrinkage required entry of extracellular Ca2+, 
erythrocytes were incubated for 48 hours in the absence or presence of 8 µg/ml Psammaplin 
Fig. 2. Effect of Psammaplin A on phosphatidylserine exposure. A. Original histogram of annexin-V-binding 
of erythrocytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) 
presence of 8 µg/ml Psammaplin A. B. Arithmetic means ± SEM (n = 8) of erythrocyte annexin-V-binding 
following incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Psammaplin 
A (2 - 8 µg/ml). For comparison, the effect of the solvent DMSO is shown (grey bar). ***(p<0.001) indicates 
significant difference from the absence of Psammaplin A (ANOVA).
Fig. 3. Effect of Psammaplin A on Fluo3 fluorescenc. A. Original histogram of Fluo3 fluorescence of erythro-
cytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) presence 
of 8 µg/ml Psammaplin A. B. Arithmetic means ± SEM (n = 13) of erythrocyte Fluo3 fluorescence following 
incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Psammaplin A (2 - 8 µg/
ml). For comparison, the effect of the solvent DMSO is shown (grey bar). ***(p<0.001) indicates significant 
difference from the absence of Psammaplin A (ANOVA).
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A in the presence or nominal absence of extracellular Ca2+. As illustrated in Fig. 4A-C, removal 
of extracellular Ca2+ did not significantly blunt the effect of Psammaplin A on forward 
scatter. Even in the absence of extracellular Ca2+, Psammaplin A significantly decreased the erythrocyte forward scatter. Thus, Psammaplin A-induced cell shrinkage was in large part 
triggered by mechanisms other than entry of extracellular Ca2+.
Similar observations were made with annexin-V-binding. Removal of extracellular Ca2+ 
did not significantly blunt the effect of Psammaplin A on the percentage of annexin-V-binding 
erythrocytes and even in the absence of extracellular Ca2+, Psammaplin A significantly 
increased the percentage of annexin-V-binding erythrocytes (Fig. 4D-F). Thus, Psammaplin A-induced cell membrane scrambling was in large part triggered by mechanisms other than 
entry of extracellular Ca2+.
Eryptosis is further stimulated by oxidative stress. Reactive oxygen species (ROS) was 
thus quantified utilizing 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA). As illustrated 
in Fig. 5A,B, the DCFDA fluorescence was significantly increased following a 48 hours 
exposure to 8 µg/ml Psammaplin. Thus, Psammaplin A induced oxidative stress.A further stimulator of eryptosis is ceramide. Ceramide abundance at the erythrocyte 
surface was thus quantified utilizing specific antibodies. As a result, the ceramide abundance 
was significantly increased following a 48 hours exposure to 8 µg/ml Psammaplin (Fig. 5C,D).
Fig. 4. Ca2+ insensitivity of Psammaplin A-induced erythrocyte shrinkage and phosphatidylserine exposure. 
A,B. Original histograms of erythrocyte forward scatter following exposure for 48 hours to Ringer solution 
without (grey area) and with (black line) Psammaplin A (8 µg/ml) in the presence (A) and absence (B) of 
extracellular Ca2+. C. Arithmetic means ± SEM (n = 13) of erythrocyte forward scatter after a 48 hours treat-
ment with Ringer solution without (white bars) or with (black bars) Psammaplin A (8 µg/ml) in the pres-
ence (left bars, +Ca2+) and absence (right bars, -Ca2+) of Ca2+. ***(p<0.001) indicates significant difference 
from the absence of Psammaplin A (ANOVA). D,E. Original histograms of annexin-V-exposing erythrocytes 
following exposure for 48 hours to Ringer solution without (grey area) and with (black line) Psammaplin A 
(8 µg/ml) in the presence (D) and absence (E) of extracellular Ca2+. F. Arithmetic means ± SEM (n = 13) of 
the percentage of annexin-V-exposing erythrocytes after a 48 hours treatment with Ringer solution without 
(white bars) or with (black bars) Psammaplin A (8 µg/ml) in the presence (left bars, +Ca2+) and absence (right bars, -Ca2+) of Ca2+. ***(p<0.001) indicates significant difference from the absence of Psammaplin A 
(ANOVA).
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DiscussionThe present study revealed a novel effect of Psammaplin A, i.e. the stimulation of eryptosis, 
the suicidal erythrocyte death. A 48 hours treatment of eythrocytes with Psammaplin A was followed by cell shrinkage and phospholipid scrambling of the cell membrane with phosphatidylserine translocation to the erythrocyte surface. The concentration required 
to trigger eryptosis was in the range of plasma concentrations (up to 5.2 ± 0.8 µg/ml) 
encountered in Psammaplin treated rats [75]. The sensitivity to Psammaplin A is presumably enhanced in several clinical conditions with accelerated eryptosis, such as dehydration [76], 
hyperphosphatemia [77], chronic kidney disease (CKD) [78-81], hemolytic-uremic syndrome 
[82], diabetes [83], hepatic failure [84], malignancy [59], sepsis [85], sickle-cell disease [59], 
beta-thalassemia [59], Hb-C and G6PD-deficiency [59], as well as Wilson’s disease [86]. The effect of Psammaplin A on cell membrane scrambling was paralleled by an increase of cytosolic Ca2+ activity ([Ca2+]i). However, the Psammaplin A induced cell membrane scrambling 
was not appreciably blunted by removal of extracellular calcium and thus not dependent on Ca2+ 
Fig. 5. Effect of Psammaplin A on DCFDA fluorescence and ceramide abundance. A. Original histogram of 
DCFDA fluorescence of erythrocytes following exposure for 48 hours to Ringer solution without (grey area) 
and with (black line) presence of 8 µg/ml Psammaplin A. B. Arithmetic means ± SEM (n = 9) of DCFDA 
fluorescence of erythrocytes following incubation for 48 hours to Ringer solution without (white bar) or 
with (black bar) Psammaplin A (8 µg/ml). ***(p<0.001) indicates significant difference from the absence of Psammaplin A (unpaired t test). C. Original histogram of ceramide abundance at the surface of eryth-
rocytes following exposure for 48 hours to Ringer solution without (grey area) and with (black line) pres-
ence of 8 µg/ml Psammaplin A. D. Arithmetic means ± SEM (n = 5) of ceramide abundance at the surface of 
erythrocytes following incubation for 48 hours to Ringer solution without (white bar) or with (black bar) 
Psammaplin A (8 µg/ml). ***(p<0.001) indicates significant difference from the absence of Psammaplin A (unpaired t test).
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entry from the extracellular space. Accordingly, the effect of Psammaplin A on cell membrane 
scrambling was accomplished even in the absence of extracellular Ca2+.The effect of Psammaplin A on cell shrinkage was again seemingly independent from Ca2+ entry from the extracellular space. Nevertheless, the Psammaplin A induced cell shrinkage could at least in part be due to increase of [Ca2+]i with subsequent activation of Ca2+ sensitive K+ channels, K+ exit, cell membrane hyperpolarization, Cl- exit and thus cellular loss of KCl with water. Mechanisms possibly contributing to Psammaplin A induced eryptosis further include 
oxidative stress and ceramide, both well known stimulators of eryptosis [59].
The physiological significance of eryptosis is the removal of defective erythrocytes from circulating blood thus avoiding hemolysis [59] with release of hemoglobin, which could 
pass the renal glomerular filter, precipitate in the acidic lumen of renal tubules, occlude 
the respective nephrons and thus cause renal failure [87]. Eryptosis may particularly lead to elimination of erythrocytes infected with the malaria pathogen Plasmodium [59]. 
It is tempting to speculate that Psammaplin A could accelerate the clearance of infected 
erythrocytes and thus favourably influence the clinical course of malaria.
Due to the rapid clearance of phosphatidylserine exposing erythrocytes from circulating blood, stimulation of eryptosis may lead, on the other hand, to anemia [59]. Excessive 
eryptosis may further compromize microcirculation [72, 88-92], as phosphatidylserine 
exposing erythrocytes adhere to the vascular wall [93], stimulate blood clotting and trigger 
thrombosis [88, 94, 95].
In conclusion, Psammaplin A triggers eryptosis with cell shrinkage and cell membrane scrambling, an effect paralleled by increase of cytosolic Ca2+ activity, oxidative stress and ceramide abundance.  
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